Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dornase Alfa for Ventilator Associated Infection in Preterm Infants
NCT01356147Phase 4Completed
- Sponsor
- Georgetown University
- Start
- May 2011
- Primary completion
- Jan 2015
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ventilator-associated pneumonia (VAP) comparing Sham placebo with Dornase alfa (2 arms). Primary endpoint: Percent Reduction in Oxygen Requirement From Baseline at 1 week. Started May 2011; status: completed.
02
Drugs
dornase alfa
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT01356147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01356147.